PRMT6 and lung carcinoma: In other tumors, downregulating PRMT6 has been shown to decrease the aggressive characteristics of endometrial, prostate, and lung cancer cells, leading to a significant reduction in their ability to migrate and invade surrounding tissues [38–40].